BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21150469)

  • 1. Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
    Baggstrom MQ; Waqar SN; Sezhiyan AK; Gilstrap E; Gao F; Morgensztern D; Govindan R
    J Thorac Oncol; 2011 Jan; 6(1):98-102. PubMed ID: 21150469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of non-small-cell lung cancer among California Hispanics according to neighborhood socioeconomic status.
    Wong ML; Clarke CA; Yang J; Hwang J; Hiatt RA; Wang S
    J Thorac Oncol; 2013 Mar; 8(3):287-94. PubMed ID: 23399956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
    Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
    Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
    Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bottleneck effect in lung cancer clinical trials.
    Gonzalez LE; Sutton SK; Pratt C; Gilbertson M; Antonia S; Quinn GP
    J Cancer Educ; 2013 Sep; 28(3):488-93. PubMed ID: 23733149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
    Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
    Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
    Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
    Lim C; Sung M; Shepherd FA; Nouriany N; Sawczak M; Paul T; Perera-Low N; Foster A; Zawisza D; Feld R; Liu G; Leighl NB
    J Thorac Oncol; 2016 Jan; 11(1):79-84. PubMed ID: 26762742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
    Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
    J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years.
    van der Drift MA; Karim-Kos HE; Siesling S; Groen HJ; Wouters MW; Coebergh JW; de Vries E; Janssen-Heijnen ML
    J Thorac Oncol; 2012 Feb; 7(2):291-8. PubMed ID: 22157366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599.
    Somer RA; Sherman E; Langer CJ
    Clin Lung Cancer; 2008 Mar; 9(2):102-5. PubMed ID: 18501096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004.
    Inoue M; Okumura M; Sawabata N; Miyaoka E; Asamura H; Yoshino I; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Kobayashi H; Yokoi K
    Lung Cancer; 2014 Feb; 83(2):246-51. PubMed ID: 24296124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, Canada.
    Booth CM; Shepherd FA; Peng Y; Darling G; Li G; Kong W; Mackillop WJ
    J Thorac Oncol; 2012 Mar; 7(3):559-66. PubMed ID: 22307012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH; Zell JA
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study.
    Tracey E; McCaughan B; Badgery-Parker T; Young J; Armstrong B
    Lung Cancer; 2015 Oct; 90(1):15-21. PubMed ID: 26275475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.